Astrazeneca Share Discussion Threads

[buywell3] 23/12/2018 22:17

....... Alzheimers' , Parkinsons are Prion Diseases and Transmissible ..........

IMO

No cure exists , hence GSK and AZN and many others have wasted Billions looking for a drug that doesn't and will never be found






The NHS knows that CJD and vCJD are prion diseases and that vCJD was transmissible by the use of prion protein residue contaminated surgical instruments being used , after the NHS cleaning/washing process ( ie not properly tested/inadequate thus transmitting vCJD from patient to patient.


The NHS has stated there are 1 in every 2000 people carrying vCJD ( or prions ) now as I key.




This is a low number they say ... but it means even on the NHS estimate that aound a minimum of 10,000 vCJD carriers in the UK ... who are having operations / using dental equipment / and having more worringly as I will explain Eye inspections and eye surgery.


The true number of carriers is in fact much higher because a more variant form of the prions associated with vCJD has recently been identified that was not tested for in the old 1 in 2000 test. More than double the incidence is therefore likely ie probably a minimum of 30,000 carriers.


However sCJD is even more common than vCJD , is a prion disease and transmissible , and in November of this year has been identified in the eyes of humans on the surface of corneas.

It’s unknown how early in the disease process prions appear in the eyes of humans, but in rodents, they are present prior to the onset of disease. About 40% of sCJD patients develop eye-related symptoms serious enough to warrant a consultation with an ophthalmologist. Somwhere between a quarter and a half go blind.

Undiagnosed CJD patients may seek testing. And the diagnostic equipment used to test them may then become contaminated, the authors write. They recommend single-use instruments or the adoption of new decontamination procedures for opthalmological equipment with better effectiveness on prions.

''corneal transplants are becoming increasingly popular worldwide. According to the authors of the link below , 185,576 were performed in 116 countries in 2012, a new high. The United States leads the world per capita, with 64,000 performed each year''

Corneal pathology is the second leading cause of blindness worldwide with 20-30 million patients in need of a remedy and around 2 million new cases/year


IMO Alzheimers and Parkinsons are being transmitted from person to person via both corneal transplants and protein reside contaminated surgical instruments and test equipment used in both the Neurology and Ophthalmology Depts of the NHS

[bountyhunter] 04/12/2018 11:38

Glad I switched now, the market view is that GSK overpaid yesterday...

[buywell3] 24/11/2018 05:59

Could cause legal claims for big Pharma doing clinical trials

[ayl30] 15/11/2018 10:47

.... and further ahead

[bountyhunter] 15/11/2018 08:25

AZN moving ahead (see chart above)

[bountyhunter] 08/11/2018 12:07

Yes it is isn't it!

Here's an update of that chart above to liven things up ;-)



Ok before anyone says it GSK pays a slightly higher dividend, however imho AZN has a better pipeline than GSK which may well prove to be more significant.

[alphorn] 08/11/2018 10:31

For such a major UK company this thread is very thin!

[alphorn] 08/11/2018 10:27

The market seems to accept the results. The FT take "AstraZeneca profits slump but company pins hopes on new drugs".

[bountyhunter] 15/10/2018 18:32

neck and neck now

[harry_david] 07/9/2018 07:10

Great news, one more new product

[bountyhunter] 30/8/2018 11:13

Liberum Downgrades GlaxoSmithKline On Valuation Grounds



which is why I made the switch to AZN which imo has a better pipeline

[thecashmoney] 27/8/2018 18:10

Check ticker nuog ,well worth a look if you're looking for growth,deal expected shortly

[thecashmoney] 27/8/2018 18:08

Just do your own research and ignore the noise is my advice,it's quite obvious that NUOG /MFDEVCO is on the cusp of transformational news .Comms from the company via tweets says negotiations are drawing to a conclusion,last rns from chairman states it's progressing .Recent podcast designed to be non promotional imvho .Think of it like buying a car ,you don't tell the other parties how much you love it ,you say it needs new tyres , exhaust is on its way out etc ,you want the best deal possible . According to my research it's a win win win for all involved. OSX-3 owners want more from their asset , dommo current operators need cash revenue to raise to develop other assets.Mfdevco obviously will be truly transformational as the podcast states it will put mfdevco in a very forward position,with most of the steps allready completed,alot of money has already been spent and will put this company in a very advanced state compared to its current market capitalisation.CM

[bountyhunter] 13/8/2018 15:59

finally AZN has inched ahead (just!)

...even though it went XD last week

[bountyhunter] 09/8/2018 08:50

thanks for correcting, nice to see the share price rise on XD day, don't see that very often

[bluemango] 09/8/2018 08:44

Lol, what ex-div fall? ;o)

[bluemango] 08/8/2018 23:29

No, not 90p, it's 90 cents or just less than 70p.

[smcni1968] 08/8/2018 20:59

ex div tomorrow

[bluemango] 07/8/2018 11:01

Nice rises continuing, weaker pound may be one factor.

[bountyhunter] 30/7/2018 12:38

sorry the first chart is when I switched, the second is from 1 Jan
...of course I've not taken dividends into account so AZN still needs to go a little higher for break even, I'm confident AZN is the best long-term of the two though due to the pipeline imho